Status:
TERMINATED
Glycemic Control and Surgical Site Infection Incidence Among Liver Transplantation Recipients
Lead Sponsor:
Ramon Oliveira
Conditions:
Liver Transplantation
Surgical Wound Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Context: The hyperglycemia is an important independent risk factor for the Surgical Site Infection (SSI) development among liver transplantation recipients. Objective: To evaluate the effects of an in...
Detailed Description
The Surgical Site Infections (SSI's) are the most frequent healthcare-associated infections and are an important infectious complication in the postoperative period among liver transplantation (LT) re...
Eligibility Criteria
Inclusion
- Recipients of LT whose allograft came from deceased donors
- Able to give informed consent personally or via a family member who has appropriate authorization to do so if patient unconscious.
- Blood glucose level over 130 mg/dL in the first 24 hours postoperatively
Exclusion
- The patients that underwent any kind of surgery with or without prosthesis implant in the 30 days before the LT
- Recipients submitted to multiple organ transplantation
Key Trial Info
Start Date :
March 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03474666
Start Date
March 11 2018
End Date
January 15 2020
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Santa Casa de São José dos Campos
São José dos Campos, São Paulo, Brazil, 12210110